GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificate

27 Jun 2024 Evaluate

Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), GlaxoSmithKline Pharmaceuticals has informed that Registrar and Transfer Agent of Company - KFin Technologies has received request for issue of duplicate Share Certificates from Shareholder, Srinivas Rangacharya Jahagirdar (Folio No: 0088321). The company will issue the Letter of Confirmation only after the necessary formalities are carried out by the Shareholder. Further details are enclosed.

The above information is a part of company’s filings submitted to BSE.


Glaxosmithkline Phar Share Price

2308.35 -71.50 (-3.00%)
23-Jan-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1629.20
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 885.00
Lupin 2170.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×